AI-Driven Breakthrough in Protein Design Unveiledby Lilu Anderson 17.08.2024AI-designed proteins transform with molecular switches, paving new paths in biotechnology innovation and drug delivery.
AI Helps ALS Patients Communicate Uniquelyby Lilu Anderson 15.08.2024Brain implants and AI voice technology enable ALS patients to communicate effectively.
AI and AR Revolutionize Dementia Careby Lilu Anderson 15.08.2024AI and AR technologies offer innovative solutions for dementia care, aiding patients and reducing caregiver burden.
Beam Therapeutics: Genetic Medicine Pioneerby Lilu Anderson 15.08.2024Beam Therapeutics leads with CRISPR in treating genetic diseases, opening new market avenues.
Addressing AI Bias in Medical Settingsby Lilu Anderson 14.08.2024Exploring the impact of AI bias in healthcare and solutions to ensure equitable patient care.
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapyby Lilu Anderson 14.08.2024Kezar halts tumor drug trials, pivots to autoimmune hepatitis focus with promising zetomipzomib.
Trinity Biotech to Announce Q2 2024 Resultsby Lilu Anderson 14.08.2024Trinity Biotech will release its Q2 2024 financial results on August 14, 2024, with a call at 8:30 AM ET ...
3 AI Stocks Poised for Exponential Growthby Lilu Anderson 13.08.2024Explore three AI stocks with potential for dramatic growth: Nano-X Imaging, Riskified, Rubrik. Learn their unique tech strategies.
Top Biotech Stocks to Watch: Expert Analysisby Lilu Anderson 13.08.2024Discover promising biotech stocks with expert insights on market trends and innovative drugmakers worth your investment.
Recursion Merges with Exscientia to Accelerate Drug Discoveryby Lilu Anderson 13.08.2024Recursion Pharmaceuticals merges with Exscientia to revolutionize drug discovery, bringing new treatments to market more quickly.